Detalles de la búsqueda
1.
Retained avidity despite reduced cross-binding and cross-neutralizing antibody levels to Omicron after SARS-COV-2 wild-type infection or mRNA double vaccination.
Front Immunol
; 14: 1196988, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37545492
2.
Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational phase 4 trial.
Lancet Microbe
; 4(8): e612-e621, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37354911
3.
Six-Month Follow-Up of Immune Responses after a Rapid Mass Vaccination against SARS-CoV-2 with BNT162b2 in the District of Schwaz/Austria.
Viruses
; 14(8)2022 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36016265
4.
Seroprevalence of SARS-CoV-2 infection in the Tyrolean district of Schwaz at the time of the rapid mass vaccination in March 2021 following B.1.351-variant outbreak.
Front Public Health
; 10: 989337, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36159252
5.
High Prevalence of Undocumented SARS-CoV-2 Infections in the Pediatric Population of the Tyrolean District of Schwaz.
Viruses
; 14(10)2022 10 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36298849
Resultados
1 -
5
de 5
1
Próxima >
>>